Genetic Technologies Limited
GNTLF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.5% | 12.3% | 590.6% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 40.4% | 58.1% | 70.2% | -18% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -118.2% | -108.3% | -78.1% | -536.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -124.2% | -113.6% | -77.4% | -530.3% |
| EPS Diluted | -0.091 | -0.12 | -0.077 | -0.083 |
| % Growth | 24.3% | -55.2% | 6.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |